期刊文献+

PPARγ磷酸化与非磷酸化的研究进展

Research Progress of Phosphorylation and Non-phosphorylation of PPARγ
下载PDF
导出
摘要 过氧化物酶体增殖物激活受体γ(PPARγ)是一种配体依赖性核转录因子,具有调控细胞分化、脂肪代谢、糖代谢及炎症等多种生物学功能。已知PPARγ有多种转录后修饰,磷酸化修饰是PPARγ第一个被鉴定的翻译后修饰方式,目前研究较多的是Ser112位点的丝裂原激活的蛋白激酶途径及Ser273位点的细胞周期素依赖的蛋白激酶5途径。PPARγ的异源二聚体结合到靶基因启动子区的特异反应元件过氧化物酶体增殖反应元件上调控靶基因的转录,PPARγ还参与炎性反应应答。PPARγ与糖尿病、肿瘤等疾病也有密切的联系。 Peroxisome proliferator activated receptor-γ(PPARγ) is a ligand-dependent transcription factor,which can regulate cell differentiation, lipid metabolism, glucose metabolism and inflammation and other biological functions. It is known that PPARγ has a variety of post-translational modifications,and phos phorylation is the first identified post-translational modification of PPARγ. The current studies on Ser112 site of the MAPK pathway and Ser273 site of the Cdk5 pathway are popular. The heterologous dimerization of PPARγ can bind to the target gene promoter region specific response element PPRE( peroxisome proliferator response elements) to regulate the transcription of the target genes. In addition ,PPARγ is also involved in the inflammatory response, and is closely linked to diabetes, cancer and other diseases.
作者 宋扬 吴荣
出处 《医学综述》 2014年第3期404-407,共4页 Medical Recapitulate
关键词 过氧化物酶体增殖物激活受体Γ 磷酸化 糖尿病 炎症 Peroxisome proliferator-activated receptor-γ Phosphorylation Diabetes Inflammation
  • 相关文献

参考文献28

  • 1Desvergne B,Wahli W. Peroxisome proliferator-activated receptors:nuclear control of metabolism.Peroxisome proliferator-activated receptors:nuclear control of metabolism[J].{H}ENDOCRINE REVIEWS,1999,(5):649-688.
  • 2Werman A,Hollenberg A,Solanes G. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma(PPARgamma) Differential activity of PPARgamma1 and-2 isoforms and influence of insulin[J].{H}Journal of Biological Chemistry,1997,(32):20230-20235.
  • 3Kliewer SA,Umesono K,Noonan DJ. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors[J].{H}NATURE,1992,(6389):771-774.
  • 4Berger J,Moller DE. The mechanisms of action of PPARs[J].{H}Annual Review of Medicine,2002,(53):409-435.
  • 5Fajas L,Fruchart JC,Auwerx J. PPARgamma3 mRNA:a distinct PPARgamma mRNA subtype tran-scribed from an independent promoter[J].{H}FEBS Letters,1998,(1/2):55-60.
  • 6Braissant O,Foufelle F,Scotto C. Differential expression of peroxisomeproliferator-activated receptors(PPARs):tissue distribution of PPAR-alpha,-beta,and-gamma in the adult rat[J].{H}ENDOCRINOLOGY,1996,(1):354-366.
  • 7Hu E,Kim JB,Sarraf P. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma[J].{H}SCIENCE,1996,(5295):2100-2103.
  • 8Camp HS,Tafuri SR,Leff T. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity[J].{H}ENDOCRINOLOGY,1999,(1):392-397.
  • 9Camp HS,Tafuri SR. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase[J].{H}Journal of Biological Chemistry,1997,(16):10811-10816.
  • 10Shao D,Rangwala SM,Bailey ST. Interdomain communication regulati ng ligand binding by PPAR-gamma[J].{H}NATURE,1998,(6709):377-380.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部